Basic Search  |  Summaries  |  Advanced Search

Violation Tracker Individual Record

Company: Senju Pharmaceutical Co., Ltd.
Penalty: $3,000,000
Year: 2018
Date: November 13, 2018
Offense Group: competition-related offenses
Primary Offense: price-fixing or anti-competitive practices
Violation Description: Senju Pharmaceutical, Kyorin Pharmaceutical and Allergan together agreed to pay $9 million to settle allegations they sold slightly different versions of the eye care product Zymar to prevent a generic version of the pink-eye treatment from entering the market. Court documents did not specify how much each company would pay. Here we assume they each paid an equal share.
Level of Government: federal
Action Type: private litigation
Court: District of Delaware
Civil or Criminal Case: civil
Case ID: 1:14cv719
Case Name: Hartig Drug Company Inc. v. Senju Pharmaceutical Co. Ltd. et al
Private Lawsuit Resolution Type: settlement
Source of Data: (click here)
Link to PACER Case Docket (must be logged in): (click here)
Link to Archived Court Document:  subscribe to see this data field
Source Notes: If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Current parent company note: Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.